Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy

Clinical trial NCT07461441 · RECRUITING

Trial details

NCT number: NCT07461441
Sponsor: Yeungnam University College of Medicine
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Polypoidal Choroidal Vasculopathy (PCV)Age Related Macular Degeneration

Start date: 2026-03-01
Primary completion: 2028-11-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.